The next step in the evolution
of brain aneurysm treatment
Conventional endovascular treatments for brain aneurysms require a significant amount of physician skill, could take hours to perform, and often require lifetime usage of high-risk anticoagulants.
There is an eminent need for a solution that facilitates a swift learning curve, comprises intuitive implantation techniques and ensures long-term patient safety and positive outcomes.
LuSeed DOME™ is a minimally invasive intrasaccular implant used for the treatment of brain aneurysms.
LuSeed DOME™’s unique dual-layered symmetric design promotes continuous coverage of the aneurysm neck with an intact wall apposition, while allowing implantation from virtually any angle, without unwanted protrusion to the parent artery and respective high-risk anticoagulants administration.
Statistics and Facts: Aneurysm Foundation website
Mesh design leads to easy delivery within the aneurysm sac at different angles, allowing simple and intuitive implantation in sidewall and bifurcation cases.
Treatment can be executed by expert (“golden hands”) and novice (“bronze hands”) physicians following a smooth, fast learning curve.
The device’s design minimizes protrusion of the implant into the arterial circulation, mitigating the need for chronic dual antiplatelet therapy (DAPT).
Suitable for ruptured cases in one simple procedure, where standard of care may involve hours of complex endovascular surgeries.
Device geometry provides a complete seal of the aneurysm neck in its entire spectrum of indications, intended to increase long-term complete occlusion rate.
Treatment times are drastically reduced – mitigating patient risk, physician radiation exposure, and hospital costs.
